TITLE

A focused review of hematopoietic neoplasms occurring in the therapy-related setting

AUTHOR(S)
Liping Zhang; Sa A. Wang
PUB. DATE
July 2014
SOURCE
International Journal of Clinical & Experimental Pathology;2014, Vol. 7 Issue 7, p3512
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
97436137

 

Related Articles

  • Therapy-related myeloid neoplasms following fludarabine, cyclophosphamide, and rituximab (FCR) treatment in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma. Zhou, Yi; Tang, Guilin; Medeiros, L Jeffrey; McDonnell, Timothy J; Keating, Michael J; Wierda, William G; Wang, Sa A // Modern Pathology;Feb2012, Vol. 25 Issue 2, p237 

    No abstract available.

  • Granulocytic sarcoma and HIV. Krause, John R.; Aburiziq, Ibrahim // Baylor University Medical Center Proceedings;Oct2011, Vol. 24 Issue 4, p306 

    Hematopoietic neoplasms are known to occur in the setting of HIV. Excluding Kaposi's sarcoma, the neoplasms are generally high-grade lymphoproliferative disorders. Granulocytic sarcoma, an extramedullary hematopoietic malignancy that may precede or occur during the course of acute myeloid...

  • Some General Considerations about the Clinicopathologic Aspects of Soft Tissue Tumors in Children and Adolescents. Coffin, Cheryl M.; Alaggio, Rita; Dehner, Louis P. // Pediatric & Developmental Pathology;Jan/Feb2012 Supplement, p11 

    Soft tissue tumors in children and adolescents are an important group of neoplasms, pseudoneoplasms, and tumefactive malformations with some distinctive clinicopathologic, genetic, syndromic, and therapeutic implications. In addition to the basic pathologic examination, there is the availability...

  • Preexisting TP53 mutation in therapy-related acute myeloid leukemia. Schulz, Eduard; Kashofer, Karl; Heitzer, Ellen; Mhatre, Ketaki; Speicher, Michael; Hoefler, Gerald; Sill, Heinz // Annals of Hematology;Mar2015, Vol. 94 Issue 3, p527 

    The article presents a case study of a 71 year-old male Caucasian patient suffering from Hodgkin lymphoma treated with chemotherapy and radiotherapy. According to classification of the World Health Organization (WHO) therapy-related myeloid neoplasms caused due to mutational events in...

  • Genetic Pathways Leading to Therapy-Related Myeloid Neoplasms. Stoddart, Angela; McNerney, Megan E.; Bartom, Elizabeth; Bergerson, Rachel; Young, David J.; Qian, Zhijian; Wang, Jianghong; Fernald, Anthony A.; Davis, Elizabeth M.; Larson, Richard A.; White, Kevin P.; Le Beau, Michelle M. // Mediterranean Journal of Hematology & Infectious Diseases;2011, Vol. 3 Issue 1, p1 

    Therapy-related myeloid neoplasm (t-MN) is a distinctive clinical syndrome occurring after exposure to chemotherapy or radiotherapy. t-MN arises in most cases from a multipotential hematopoietic stem cell or, less commonly, in a lineage committed progenitor cell. The prognosis for patients with...

  • Allogeneic Hematopoietic Cell Transplantation for Therapy-Related Myeloid Leukemia following Orthotopic Cardiac Transplantation. Lin, Richard J.; Larson, Richard A.; van Besien, Koen; Rich, Elizabeth S. // Case Reports in Hematology;2013, p1 

    Therapy-related myeloid neoplasm (t-MN) is a subtype of acute myeloid leukemia with adverse cytogenetics and poor overall prognosis despite intensive induction chemotherapy and allogeneic hematopoietic cell transplantation (allo-HCT). It is increasingly recognized as a late complication of...

  • Prognosis and Therapy When Acute Promyelocytic Leukemia and Other "Good Risk" Acute Myeloid Leukemias Occur as a Therapy-Related Myeloid Neoplasm. Larson, Richard A.; Le Beau, Michelle M. // Mediterranean Journal of Hematology & Infectious Diseases;2011, Vol. 3 Issue 1, p1 

    Treatment for a pre-existing condition using chemotherapy, radiation therapy, immunosuppressive therapy, or a combination of these modalities may lead to the devastating complication of therapy-related myelodysplastic syndrome or acute myeloid leukemia (t-MDS/t-AML), collectively known as...

  • Incidence of Acute Myeloid Leukemia after Breast Cancer. Valentini, Caterina Giovanna; Fianchi, Luana; Voso, Maria Teresa; Caira, Morena; Leone, Giuseppe; Pagano, Livio // Mediterranean Journal of Hematology & Infectious Diseases;2011, Vol. 3 Issue 1, p1 

    Breast cancer is the most frequent cancer among women and the leading cause of death among middle-aged women. Early detection by mammography screening and improvement of therapeutic options have increased breast cancer survival rates, with the consequence that late side effects of cancer...

  • Therapy-related myeloid neoplasms. Magdalena Czader; Attilio Orazi // American Journal of Clinical Pathology;Sep2009, Vol. 132 Issue 3, p410 

    Session 5 of 2007 Workshop of the Society for Hematopathology/European Association for Haematopathology focused on therapy-related myeloid neoplasms. This report discusses the diversity and relevance of clinical, pathologic, and genetic features and provides an update on the pathogenesis of...

  • Notch Signaling in Leukemias and Lymphomas. Jundt, Franziska; Schwarzer, Rolf; D�rken, Bernd // Current Molecular Medicine;Feb2008, Vol. 8 Issue 1, p51 

    Aberrant Notch activation is linked to cancer since 1991 when mammalian Notch1 was first identified as part of the translocation t(7;9) in a subset of human T-cell acute lymphoblastic leukemias (T-ALL). Since then oncogenic Notch signaling has been found in many solid and hematopoietic...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics